言語を選択
新規登録

CCR5

CCR5 詳細

英語名C-C chemokine receptor type 5市販薬剤の数1
治験薬の数13ターゲットの別称CCR-5，Chemokine (C-C Motif) Receptor 5 (Gene/Pseudogene)，C-C Motif Chemokine Receptor 5 A159A，Chemokine Recptor CCR5 Delta32，C-C Chemokine Receptor Type 5，Chemokine Receptor CCR5，CD195 Antigen，C-C CKR-5，CCCKR5，IDDM22，CKR-5，CKR5，Receptors， CCR5，C-C Motif Chemokine Receptor 5，CD195，CHEMR13，CCR5，HIV-1 fusion coreceptor，C-C Motif Chemokine Receptor 5 (Gene/Pseudogene)，Chemokine (C-C Motif) Receptor 5，CC-CKR-5，CMKBR5
研究＆開発段階Approved
英語名C-C chemokine receptor type 5
ターゲットの別称CCR-5，Chemokine (C-C Motif) Receptor 5 (Gene/Pseudogene)，C-C Motif Chemokine Receptor 5 A159A，Chemokine Recptor CCR5 Delta32，C-C Chemokine Receptor Type 5，Chemokine Receptor CCR5，CD195 Antigen，C-C CKR-5，CCCKR5，IDDM22，CKR-5，CKR5，Receptors， CCR5，C-C Motif Chemokine Receptor 5，CD195，CHEMR13，CCR5，HIV-1 fusion coreceptor，C-C Motif Chemokine Receptor 5 (Gene/Pseudogene)，Chemokine (C-C Motif) Receptor 5，CC-CKR-5，CMKBR5
市販薬剤の数1
治験薬の数13
研究＆開発段階Approved

CCR5 製品リスト

  • 属性

    Protein (4)Cell (1)

  • 製品ライブラリ

    オンライン (5)

  • 種

    Human (4)Mouse (1)

  • タグ

    His Tag & Flag Tag (2)- (2)GFP Tag (1)

  • マーカー

    Unconjugated (3)- (1)GFP Fusion (1)

製品番号種発現システム製品説明タンパク質の構造純度特性
HOT
CC5-H52D1
Human
HEK293
Human CCR5 Protein, Flag,His Tag (Detergent)
HOT
CC5-H52P3
Human
HEK293
Human CCR5 Full Length Protein (VLP)
HOT
CC5-M52D9
Mouse
HEK293
Mouse CCR5 Protein, Flag,His Tag (Detergent)
CC5-H52P5
Human
HEK293
Fluorescent Human CCR5 Full Length Protein (VLP)
CHEK-ATP043
Human
HEK293
HEK293/Human CCR5 Stable Cell Line
総数量5
  • 1

CCR5分子の別称

CCR5,CMKBR5,CD195,CC-CKR-5,CHEMR13

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Cenicriviroc mesylateCCR5/CCR2 antagonist; TBR-652; CVC; TAK-652Phase 3 ClinicalTakeda Pharmaceutical Co Ltd, Tobira Therapeutics IncAIDS Dementia Complex; Cholangitis, Sclerosing; Cognition Disorders; Coronavirus Disease 2019 (COVID-19); Diabetes Mellitus, Type 2; Hepatic Insufficiency; HIV Infections; Liver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Prediabetic State
詳細
SB-728-TSB-728mR-T; SB-728-TPhase 2 ClinicalSangamo BiosciencesHIV Infections
詳細
VicrivirocSCH-D; MK-4176; SCH-417; Sch-417690Phase 2 ClinicalMerck & Co IncAcquired Immunodeficiency Syndrome; Colorectal Neoplasms; HIV Infections
詳細
LeronlimabPA-14; PRO-140; HuPRO-140Phase 2 ClinicalProgenics Pharmaceuticals IncColorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; HIV Infections; Metabolic Dysfunction-Associated Steatotic Liver Disease; Rectal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
詳細
BMS-813160BMS-813160Phase 2 ClinicalBristol-Myers Squibb CompanyAdenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Diabetic Nephropathies; Hyperplasia; Pancreatic Neoplasms
詳細
RAP-103RAP-160; RAP-701; RAP-164; RAP-310; RAP-163; RAP-103Phase 2 ClinicalRapid PharmaceuticalsAlzheimer Disease; Hepatitis B; Neuralgia; Ovarian Neoplasms; Prostatic Neoplasms; Psoriasis
詳細
Cenicriviroc mesylate/TropifexorLJC-242Phase 2 ClinicalNovartis Pharma AgMetabolic Dysfunction-Associated Steatotic Liver Disease
詳細
AGT 103-TAGT 103-TPhase 1 ClinicalAmerican Gene Technologies International IncHIV Infections
詳細
ThioravirocPhase 1 ClinicalShanghai Institute Of Materia Medica, Chinese Academy Of SciencesAmyotrophic Lateral Sclerosis; HIV Infections; Multiple Sclerosis
詳細
BMS-687681BMS-687681Phase 1 ClinicalBristol-Myers Squibb CompanyNeoplasms
詳細
SB-728-HSCSB-728-HSC; SB-728-HSPC; SB-728mR-HSPCPhase 1 ClinicalSangamo BiosciencesHIV Infections
詳細
vMIP (Guangzhou Hongrun Biotech)Phase 1 ClinicalGuangzhou Hongrun Biotechnology Co LtdPneumonia
詳細
LF-0376LF-0376Phase 1 ClinicalWuxi Hillhouse biomedicine Technology Co LtdColorectal Neoplasms; Liver Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Pancreatic Neoplasms; Solid tumours
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
MaravirocMVC; UK-427857ApprovedViiv HealthcareCelsentri, SelzentryUnited StatesHIV InfectionsViiv Healthcare Co2007-08-06Acquired Immunodeficiency Syndrome; Acute Lung Injury; AIDS Dementia Complex; Arthritis, Rheumatoid; Cardiovascular Diseases; Cognition Disorders; Coronavirus Disease 2019 (COVID-19); HIV Infections; Hypertriglyceridemia; Inflammation; Ischemic Stroke; Kidney Diseases; Primary Graft Dysfunction; Rejection of lung transplantation; Sarcoma, Kaposi; Stroke
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8